{
    "project_id": "171208",
    "broad_study_type": "other",
    "narrow_study_type": "mechanistic_study",
    "trial_phase": "N/A",
    "observational_timeframe": "N/A",
    "justification": "We propose a series of experiments to delineate the exact mechanisms by which pRb inhibits autophagy in vitro and in vivo in both differentiating myoblasts and post-mitotic muscles and well as define the role of E2F1-3, the major targets of pRb, in the induction of autophagy in Rb deficient cells.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "These results have important implications both to cancer therapy as they suggest that Rb deficient tumors can be induced to differentiate, and to muscular diseases, as autophagy plays an important role in muscle atrophy and several types of muscular dystrophies.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "unclear",
    "gender_focus": "unclear",
    "vulnerable_populations": "no",
    "rare_disease": "no",
    "population_description": "N/A",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "experimental_control",
    "dose_response": "unclear",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "inhibition of autophagy by the pRb tumor suppressor",
    "primary_outcome_type": "biomarker",
    "safety_focus": "no",
    "quality_of_life": "no",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "no",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "no",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "cancer",
    "disease_stage": "unclear",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "medium_term",
    "multicenter": "no",
    "healthcare_setting": "laboratory",
    "disease_area": "cancer, muscular diseases",
    "methodology_innovation": "delineating the mechanisms by which the pRb tumor suppressor inhibits autophagy in muscle differentiation and cancer",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 